You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) PHENOXYETHANOL


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing PHENOXYETHANOL excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing PHENOXYETHANOL excipient

Market Dynamics and Financial Trajectory for Phenoxyethanol

Last updated: February 21, 2026

Phenoxyethanol has established itself as a key preservative in the pharmaceutical excipient sector. Its safety profile, broad-spectrum antimicrobial activity, and regulatory acceptance position it as a preferred alternative to parabens and formaldehyde-releasing preservatives. The market is influenced by regulatory shifts, demand for preservative-free products, and growth in the pharmaceutical and cosmetics industries.

Market Overview

The global phenoxyethanol market was valued at approximately USD 350 million in 2022. It is projected to grow at a compound annual growth rate (CAGR) of around 6% from 2023 to 2030, reaching an estimated USD 560 million by 2030.

Key Market Drivers

  • Regulatory Environment: Increasing regulatory scrutiny over parabens and formaldehyde releasers drives demand for safer preservatives like phenoxyethanol. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) approve phenoxyethanol at concentrations up to 1% for topical pharmaceuticals and cosmetics.
  • Consumer Preference: Rising consumer awareness regarding preservative safety fuels demand for phenoxyethanol in personal care products.
  • Pharmaceutical Applications: Its stability and compatibility with APIs make phenoxyethanol suitable for injectables and topical formulations, especially in sterile environments.
  • Cosmetics Sector Growth: The cosmetics industry's expansion compels manufacturers to adopt phenoxyethanol to meet safety standards and shelf life requirements.

Market Segmentation

Segment Market Share (2022) Growth Rate (2023-2030) Key Users
Personal Care & Cosmetics 60% 6% CAGR Lotions, shampoos, deodorants
Pharmaceuticals 30% 5.5% CAGR Topical creams, injectables
Animal Care 10% 4.5% CAGR Veterinary formulations

Competitive Landscape

Major players include:

  • BASF SE: Produces phenoxyethanol primarily for cosmetics and pharmaceuticals.
  • Shandong Fine Chemicals: Focuses on North American and Asian markets.
  • LANXESS AG: Offers phenoxyethanol as part of its preservatives portfolio.

Market share is consolidated among these firms, with R&D investments aimed at improving purity and reducing impurities to meet stringent regulatory standards.

Regulatory and Policy Context

  • The European Union (EU) restricts phenoxyethanol in cosmetics to a maximum concentration of 1%. It is permitted in pharmaceuticals without specific restrictions but requires compliance with good manufacturing practices.
  • The FDA approves phenoxyethanol for injectable drugs at concentrations up to 1%, adhering to USP standards.
  • In some markets, concerns over allergic reactions limit its use, prompting R&D to develop alternative preservatives.

Financial Trajectory

Revenue growth is poised to be steady due to expanding application scopes and regulatory support. The primary revenue streams are from cosmetic preservatives (~60%) and pharmaceutical excipients (~30%).

Estimated Revenue by Sector (2023-2030):

Year Cosmetics & Personal Care (USD Millions) Pharmaceuticals (USD Millions) Total (USD Millions)
2023 210 70 280
2025 270 90 360
2027 330 105 435
2030 420 140 560

Growth is driven by increased demand in emerging markets, particularly in Asia-Pacific, which accounts for roughly 40% of the total market by 2030.

Pricing Trends

Average prices for phenoxyethanol have decreased marginally due to supplier consolidation, but premium formulations with higher purity levels command higher prices. Standard-grade phenoxyethanol sells between USD 4-6 per kilogram, while pharmaceutical-grade products may reach USD 8-12 per kilogram.

Future Outlook

Innovation in preservative systems, regulatory shifts favoring non-paraben formulations, and growth in endemic-use cases such as sterile injectables underpin optimistic market projections. Companies investing in R&D to improve product purity, reduce impurities, and develop biodegradable alternatives will likely outperform.


Key Takeaways

  • Phenoxyethanol market to reach USD 560 million by 2030 at 6% CAGR.
  • Growth driven by cosmetics and pharmaceutical sectors, with Asia-Pacific leading.
  • Regulatory standards favor its use, although some restrictions exist.
  • Market consolidation among key players persists, with ongoing innovation in purity and application.
  • Price trends remain stable with premium products commanding higher margins.

Frequently Asked Questions

Q1: What are the main applications of phenoxyethanol?
A: It serves as a preservative in cosmetics, personal care products, pharmaceuticals, and animal health formulations.

Q2: How do regulatory restrictions vary globally?
A: The EU limits phenoxyethanol to 1% in cosmetics; the US approves at concentrations up to 1% for injectable drugs; some markets restrict its use due to allergy concerns.

Q3: Which regions drive market growth?
A: Asia-Pacific, especially China and India, are projected to lead growth due to expanding cosmetics and pharmaceutical manufacturing.

Q4: What are the competitive advantages of phenoxyethanol producers?
A: High purity, regulatory compliance, stable supply chains, and R&D capabilities.

Q5: What are potential risks for the market?
A: Regulatory restrictions, consumer preference shifts toward natural preservatives, and supply chain disruptions affecting raw material costs.


References

[1] MarketWatch. (2023). Phenoxyethanol Market Size, Share, Growth, and Trends Analysis.
[2] European Medicines Agency. (2022). Guidelines on preservatives in pharmaceuticals.
[3] U.S. Food and Drug Administration. (2022). Pharmaceutical excipients overview.
[4] Grand View Research. (2022). Preservatives Market Analysis.
[5] Lanxess. (2021). Preservatives Portfolio Data Sheet.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.